Condition
Concurrent Chemoradiotherapy clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Concurrent Chemoradiotherapy clinical trials that are recruiting, in China. By phase: Phase 2 (2), Phase 2/3 (1), Phase 3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest Concurrent Chemoradiotherapy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Concurrent chemoradiotherapy with surufatinib and tislelizumab for unresectable stage III non-small cell lung cancer | Phase 2 | Guangzhou, Guangdong | Recruiting | Jul 25, 2025 |
| Combination of immunotherapy and chemotherapy for advanced lung cancer | Phase 3 | Guangzhou, Guangdong | Recruiting | Dec 16, 2024 |
| Treatment for advanced cervical cancer using chemoradiotherapy and immunotherapy | Phase 1/2 | Shanghai | Recruiting | Apr 30, 2024 |
| Immunotherapy with radiotherapy and nutrition support for advanced esophageal cancer in patients who can’t tolerate standard chemoradiation | Phase 2 | Beijing, Beijing Municipality and 9 other locations | Recruiting | Apr 2, 2024 |
| Comparing neoadjuvant chemoimmunotherapy and concurrent chemoradiotherapy for locally advanced cervical cancer | Phase 2/3 | Hefei, Anhui and 11 other locations | Recruiting | Mar 1, 2024 |
All recruiting trials (5)
-
Concurrent chemoradiotherapy with surufatinib and tislelizumab for unresectable stage III non-small cell lung cancer
This tests whether adding surufatinib and tislelizumab to standard concurrent chemoradiotherapy, followed by continuing both drugs as consolidation, helps people with unresectable stage III non-small cell lung cancer.
-
Combination of immunotherapy and chemotherapy for advanced lung cancer
This study is testing if a new combination of immunotherapy and chemotherapy can help people with advanced lung cancer do better than the usual treatment.
-
Treatment for advanced cervical cancer using chemoradiotherapy and immunotherapy
This study is testing a new treatment combining chemotherapy and immunotherapy to see if it helps people with advanced cervical cancer feel better and live longer.
-
Immunotherapy with radiotherapy and nutrition support for advanced esophageal cancer in patients who can’t tolerate standard chemoradiation
This trial tests whether adding a PD-1 inhibitor (sintilimab) to radiotherapy plus specialized nutrition helps patients with locally advanced esophageal squamous cell carcinoma who can’t tolerate standard chemoradiation.
-
Comparing neoadjuvant chemoimmunotherapy and concurrent chemoradiotherapy for locally advanced cervical cancer
This study is testing whether a new treatment combining chemoimmunotherapy and surgery can help people with locally advanced cervical cancer do better than the standard treatment of chemo and radiation.
Related topics
Quick answers
How many Concurrent Chemoradiotherapy clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 2/3: 1, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.